Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1961 1
1963 2
1964 2
1967 3
1968 1
1969 1
1970 4
1971 4
1972 1
1973 6
1974 4
1976 6
1977 2
1978 3
1979 6
1980 4
1981 5
1982 7
1983 5
1984 6
1985 8
1986 6
1987 7
1988 7
1989 9
1990 13
1991 33
1992 11
1993 12
1994 17
1995 17
1996 10
1997 18
1998 10
1999 25
2000 28
2001 36
2002 30
2003 15
2004 37
2005 28
2006 37
2007 29
2008 32
2009 32
2010 45
2011 46
2012 57
2013 51
2014 80
2015 59
2016 60
2017 61
2018 72
2019 68
2020 73
2021 97
2022 66
2023 85
2024 60
2025 82
2026 38

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,536 results

Results by year

Filters applied: . Clear all
Page 1
Osteoporosis in Systemic Mastocytosis: A Scoping Review.
Letizia Mauro G, Accomando J, Tomasello S, Duca A, Mangano MS, de Sire A, Vecchio M, Scaturro D. Letizia Mauro G, et al. Medicina (Kaunas). 2024 Oct 24;60(11):1752. doi: 10.3390/medicina60111752. Medicina (Kaunas). 2024. PMID: 39596937 Free PMC article.
Objective: The aim of this scoping review was to provide an overview of secondary osteoporosis in systemic mastocytosis (SM), focusing on the heterogeneity of its manifestations, the benefits of early diagnosis, and appropriate pharmacological treatment. ...Conclusi …
Objective: The aim of this scoping review was to provide an overview of secondary osteoporosis in systemic mastocytosis (SM), …
Cutaneous mastocytosis: A dermatological perspective.
Di Raimondo C, Del Duca E, Silvaggio D, Di Prete M, Lombardo P, Mazzeo M, Spallone G, Campione E, Botti E, Bianchi L. Di Raimondo C, et al. Australas J Dermatol. 2021 Feb;62(1):e1-e7. doi: 10.1111/ajd.13443. Epub 2020 Oct 11. Australas J Dermatol. 2021. PMID: 33040350 Review.
Cutaneous mastocytosis is classified into (i) maculopapular cutaneous mastocytosis, also known as urticaria pigmentosa; (ii) diffuse cutaneous mastocytosis; and (iii) mastocytoma of the skin. ...This short review describes pathogenesis and clinical asp …
Cutaneous mastocytosis is classified into (i) maculopapular cutaneous mastocytosis, also known as urticaria pigmentosa; (ii) d …
Systemic mastocytosis--a systematic review.
Andersen CL, Kristensen TK, Severinsen MT, Møller MB, Vestergaard H, Bergmann OJ, Hasselbalch HC, Bjerrum OW. Andersen CL, et al. Dan Med J. 2012 Mar;59(3):A4397. Dan Med J. 2012. PMID: 22381091 Free article.
It is not until recent decades that the evolution of the cell has been described and its fascinating biology has only recently been depicted. We here give a review of systemic mastocytosis in regards to cell biology, diagnostic approaches and clinical practice. ...I …
It is not until recent decades that the evolution of the cell has been described and its fascinating biology has only recently been depicted …
Systemic Mastocytosis: State of the Art.
Farmer I, Radia DH. Farmer I, et al. Curr Hematol Malig Rep. 2024 Oct;19(5):197-207. doi: 10.1007/s11899-024-00737-8. Epub 2024 Aug 27. Curr Hematol Malig Rep. 2024. PMID: 39187708 Review.
PURPOSE OF REVIEW: Since identification of Systemic mastocytosis (SM) as a distinct disease entity by the World Health Organisation (WHO), there has been a wealth of new research in therapeutic targeting of the pathogenic C-KIT D816V mutation. ...The importance of m …
PURPOSE OF REVIEW: Since identification of Systemic mastocytosis (SM) as a distinct disease entity by the World Health Organis …
The international consensus classification of mastocytosis and related entities.
Leguit RJ, Wang SA, George TI, Tzankov A, Orazi A. Leguit RJ, et al. Virchows Arch. 2023 Jan;482(1):99-112. doi: 10.1007/s00428-022-03423-3. Epub 2022 Oct 10. Virchows Arch. 2023. PMID: 36214901 Review.
This includes indolent forms such as indolent systemic mastocytosis and its subvariant bone marrow mastocytosis, and smoldering systemic mastocytosis as well as aggressive forms including aggressive systemic mastocytosis, systemic mastocytosis w …
This includes indolent forms such as indolent systemic mastocytosis and its subvariant bone marrow mastocytosis, and smolderin …
Mast Cells, Mastocytosis, and Related Disorders.
Theoharides TC, Valent P, Akin C. Theoharides TC, et al. N Engl J Med. 2015 Jul 9;373(2):163-72. doi: 10.1056/NEJMra1409760. N Engl J Med. 2015. PMID: 26154789 Review. No abstract available.
Diffuse Cutaneous Mastocytosis: A Current Understanding of a Rare Disease.
Rydz A, Lange M, Ługowska-Umer H, Sikorska M, Nowicki RJ, Morales-Cabeza C, Alvarez-Twose I. Rydz A, et al. Int J Mol Sci. 2024 Jan 23;25(3):1401. doi: 10.3390/ijms25031401. Int J Mol Sci. 2024. PMID: 38338679 Free PMC article. Review.
Mastocytosis is a heterogeneous disease characterized by the expansion and accumulation of neoplastic mast cells in various tissues. Diffuse cutaneous mastocytosis (DCM) is a rare and most severe form of cutaneous mastocytosis, which typically occurs in child …
Mastocytosis is a heterogeneous disease characterized by the expansion and accumulation of neoplastic mast cells in various tissues. …
Mastocytosis.
Carter MC, Metcalfe DD, Komarow HD. Carter MC, et al. Immunol Allergy Clin North Am. 2014 Feb;34(1):181-96. doi: 10.1016/j.iac.2013.09.001. Epub 2013 Oct 7. Immunol Allergy Clin North Am. 2014. PMID: 24262698 Free PMC article. Review.
Mastocytosis is a disorder of abnormal mast cell proliferation, with clinical features that include flushing, pruritus, abdominal pain, diarrhea, hypotension, syncope, and musculoskeletal pain. ...This article discusses the causes and pathogenesis of mastocytosis, w …
Mastocytosis is a disorder of abnormal mast cell proliferation, with clinical features that include flushing, pruritus, abdominal pai …
Systemic mastocytosis: current status and challenges in 2024.
Ustun C, Keklik Karadag F, Linden MA, Valent P, Akin C. Ustun C, et al. Blood Adv. 2025 May 13;9(9):2048-2062. doi: 10.1182/bloodadvances.2024012612. Blood Adv. 2025. PMID: 39853317 Free PMC article. Review.
Systemic mastocytosis (SM) is a rare disease and has had significant discoveries in its biology, prognostication, and management in the past 2 decades. ...Prospective studies evaluating drugs with different mechanisms of action are needed for such patients. This review …
Systemic mastocytosis (SM) is a rare disease and has had significant discoveries in its biology, prognostication, and management in t …
1,536 results